Integrated Stroke System Model Expands Availability of Endovascular Therapy While Maintaining Quality Outcomes

The optimal endovascular stroke therapy (EVT) care delivery structure is unknown. Here, we present our experience in creating an integrated stroke system (ISS) to expand EVT availability throughout our region while maintaining hospital and physician quality standards. We identified all consecutive p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stroke (1970) 2021-03, Vol.52 (3), p.1022-1029
Hauptverfasser: Lopez-Rivera, Victor, Salazar-Marioni, Sergio, Abdelkhaleq, Rania, Savitz, Sean I., Czap, Alexandra L., Alderazi, Yazan J., Chen, Peng R., Grotta, James C., Blackburn, Spiros L., Jones, Wesley, Spiegel, Gary, Dannenbaum, Mark J., Wu, Tzu-Ching, Cochran, Joseph, Kim, Dong H., Day, Arthur L., Farquhar, Grace, McCullough, Louise D., Sheth, Sunil A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The optimal endovascular stroke therapy (EVT) care delivery structure is unknown. Here, we present our experience in creating an integrated stroke system (ISS) to expand EVT availability throughout our region while maintaining hospital and physician quality standards. We identified all consecutive patients with large vessel occlusion acute ischemic stroke treated with EVT from January 2014 to February 2019 in our health care system. In October 2017, we implemented the ISS, in which 3 additional hospitals (4 total) became EVT-performing hospitals (EPHs) and physicians were rotated between all centers. The cohort was divided by time into pre-ISS and post-ISS, and the primary outcome was time from stroke onset to EPH arrival. Secondary outcomes included hospital and procedural quality metrics. We performed an external validation using data from the Southeast Texas Regional Advisory Council. Among 513 patients with large vessel occlusion acute ischemic stroke treated with EVT, 58% were treated pre-ISS and 43% post-ISS. Over the study period, EVT procedural volume increased overall but remained relatively low at the 3 new EPHs (
ISSN:0039-2499
1524-4628
DOI:10.1161/STROKEAHA.120.032710